BioSig Technologies, Inc. (BSGM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. on February 25, 2021. The registrant is incorporated in Delaware and operates under the trading symbol BSGM on The NASDAQ Capital Market. The filing serves as a Regulation FD disclosure regarding the distribution of a corporate presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document solely announces the availability of a slide presentation for the investment community.
Guidance, Outlook, and Risks
The Company intends to utilize a slide presentation (attached as Exhibit 99.1, "Corporate Presentation, Winter 2021") at various industry conferences. The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the materials in the presentation. Furthermore, the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 ("Corporate Presentation, Winter 2021") for specific business updates or financial projections, as they are not included in the 8-K text.
- Note that the presentation materials are not legally "filed" and the company disclaims any obligation to update them.
- Confirm the company's current status on The NASDAQ Capital Market under the symbol BSGM.
- Review the company's most recent 10-K or 10-Q filings for actual financial data, as this 8-K contains none.